Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.950
+0.025 (0.86%)
Aug 15, 2025, 12:34 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Cell-based Therapeutics
2.54M
Log In
Log In
Log In
Log In
Upgrade
Cell-based Therapeutics Growth
48.80%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
2.54M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
48.80%
Log In
Log In
Log In
Log In
Upgrade